ZIM
ADAP

Zacks Investment Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Zacks Investment Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,418
Closed -$103K – 518
2017
Q4 		$103K Buy
+15,418
New +$103K ﹤0.01% 555